-
Sector Analysis
HER2 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
HER2 tests Market Report Overview The HER2 tests market size was valued at $123.6 million in 2023. The HER2 tests market will grow at a CAGR of more than 1% from 2023 to 2033. HER2 Testing includes extracting a sample of tumor tissue in a procedure called biopsy, which may be either fine-needle aspiration biopsy, core needle or surgical biopsy. HER2 status can also be determined by next-generation sequencing and array comparative genomic hybridization (aCGH). HER2 tests Market Outlook 2023-2033...
-
Sector Analysis
BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
BRCA Tests Market Report Overview The BRCA Tests market size was $12.9 million in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Breast cancer type 1 (BRCA1) and Breast cancer type 1 (BRCA1 gene tests, under the overall umbrella of BRCA Tests) are carried out to detect gene rearrangements within blood samples. The outcome of this may guide therapies and prophylactic actions to treat or prevent certain types of breast and ovarian...
-
Sector Analysis
BCR-ABL Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
BCR-ABL Tests Market Report Overview The BCR-ABL Tests market size was valued at $23.5 million in 2023. The market is expected to grow at a CAGR of more than 5% during 2023-2033. Breakpoint Cluster Region - Tyrosine-Protein Kinase ABL1 fusion gene (BCR-ABL) tests are carried out to detect fusion gene mutations in patient tissue samples. The outcome may guide therapies to treat various cancers including chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and acute myelogenous leukemia (AML). BCR-ABL Tests...
-
Sector Analysis
EGFR Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
EGFR Tests Market Report Overview The EGFR tests market size was $17.4 million in 2023 and it will grow at a CAGR of less than 1% during 2023-2033. Epidermal growth factor receptor gene (EGFR) tests are carried out to detect mutations within this receptor gene in non-small cell lung cancer tumor cells. The outcome of may determine if EGFR-targeted tyrosine kinase inhibitors such as gefitinib and erlotinib may be beneficial for treating non-small cell lung cancer (NSCLC). EGFR Tests Market...
-
Sector Analysis
BRAF Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
BRAF Tests Market Report Overview The BRAF Tests market size was valued at $32.8 million in 2023. The market is expected to grow at a CAGR of more than 6% during 2023-2033. BRAF Sanger sequencing Tests are used when complete sequencing of the BRAF gene is required for accurate detection and mapping of mutations. Sanger sequencing is a DNA sequencing technique that uses modified, chain-terminating dideoxynucleotides (ddNTPs). BRAF Tests Market Outlook 2023-2023 ($ Million) Buy The Full Report for More...
-
Sector Analysis
KRAS Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
KRAS Tests Market Report Overview The KRAS tests market size was $80.4 million in 2023. The market is expected to grow at a CAGR of more than 6% during 2023-2033. Kirsten rat sarcoma virus (KRAS) gene tests are carried out to detect gene mutations in patient tissue samples. The outcome of these tests may guide therapies to treat various cancers including colorectal cancer, certain lung cancers, and some leukemias. KRAS Tests Market Outlook, 2023-2033 ($ Million) Buy the Full Report...
-
Sector Analysis
ALK Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
ALK Tests Market Report Overview The ALK Tests market size was valued at $27.3 million in 2023. The market is expected to grow at a CAGR of more than 2% during 2023-2033. Anaplastic Lymphoma Receptor Tyrosine Kinase (ALK) gene tests are carried out to detect gene rearrangements within non-small cell lung cancer tumor cells, the outcome of which may guide therapies to treat non-small cell lung cancer (NSCLC). ALK Tests Market Outlook 2023-2023 ($ Million) Buy The Full Report for...
-
Product Insights
Colorectal Cancer Screening Tests Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Colorectal Cancer Screening Tests Pipeline Market Report Overview The colorectal cancer screening Tests pipeline market research report provides comprehensive information about the colorectal cancer screening tests pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Other Colorectal Cancer Screening Tests ·       Fecal DNA Test Kits ·       Immunochemical Fecal Occult Blood Test (iFOBT or FIT) Kits Key Territories ·       The US ·       Europe...